Cerenetex, Inc. is a privately held development stage Company founded to develop novel noninvasive products for the assessment of neurological conditions. Mission Strokes affect 15 million people worldwide and are a leading cause of disability and death in the world. At Cerenetex, we're leading the science of objectively diagnosing Large Vessel Occlusion (LVO) ischemic strokes to minimize the delay-in-care and injury to the brain. Vision Create a technology that complements subjective neuro tests, enhances patient triage accuracy and accelerates time to treatment for LVO strokes. It all started with a big idea... We questioned the status quo of how LVOs are detected, monitored and managed, understanding the current way of screening for LVOs is wide off the mark of a gold-standard method. Our big idea is a stethoscope for the brain For EMS and clinicians who are dissatisfied with the status quo in LVO detection, our big idea is a noninvasive screening device that provides real-time brain assessment, CereView Stroke. How CereView works CereView Stroke is a passive listening device that listens to sounds in the head created by the cardiac cycle and complex reactions through the vasculature. CereView Stroke CereView Stroke offers a simple to use, low-cost screening device to detect LVOs in the field or hospital. Using a wireless headset that connects wirelessly to a tablet, the device can be easily placed on the patient for rapid LVO assessment.